Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Add filters

Document Type
Year range
2020 Joint 11th International Conference on Soft Computing and Intelligent Systems and 21st International Symposium on Advanced Intelligent Systems ; : 143-148, 2020.
Article in English | Web of Science | ID: covidwho-1324950


Socially isolated and exposed to lonely situations affect states of health and lifespan. Under these circumstances, the social distance caused by COVID-19 is accelerating people's isolation. Therefore, we should consider how we prepare for the post COVID-19 era. One of the solutions is the introduction of robot partners as community centric system. In this paper, we show the current state about our development of socially embedded robot partner. First, we show several examples of development of robot partners. Next, we explain the modular structured systems used for robot partners. Finally, we show several examples of the effectiveness of robot partner system, and discuss the applicability of the proposed system.

European Journal of Inflammation ; 18, 2020.
Article in English | EMBASE | ID: covidwho-802444


Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December 2019 in Wuhan, China, and has resulted in global pandemic. There is currently no effective therapeutic strategy for the management of mechanical ventilation or antiviral drugs for the treatment of this disease. As such, the development of a therapeutic strategy is urgently needed and should be established as soon as possible. In this case series, a therapeutic strategy was initially developed based on previous treatment methods used for the treatment of SARS and MERS in the absence of treatment options for COVID-19 due to a lack of information. During the search for a potential treatment, clinical findings were obtained from patients with severe COVID-19, and one therapeutic strategy was established. This therapeutic strategy was then applied to severe COVID-19 patients. In addition, we can require some interesting clinical features and characteristics of COVID-19 from blood analysis and physical findings. Here, we reported on the clinical features and characteristics of a therapeutic strategy for the treatment of severe COVID-19 pneumonia at our institution.